2013-01-08 00:43:35 -
SAN FRANCISCO, CA -- (Marketwire) -- 01/07/13 -- Fullpower® today announced it has received a collection of patents covering key breakthrough technologies for wearable non-invasive medical devices.
"The next social paradigm-shift is non-invasive wearable wireless medical devices and applications," said Philippe Kahn, founder and CEO of Fullpower. "It's all about invention, innovation and IP. The combination of synergistic inventions and innovation are game-changers." See interview: http://youtu.be/gk3ppCElxwA : ctt.marketwire.com/?release=971734&id=2453269&type=1& ..
An Example related to outbreaks, epidemics and the optimal use of pharmaceutical drugs such as Tamiflu®
The patent for invention number 8,187,182 outlines a method and apparatus using sensor fusion for accurate activity identification, and the patent for invention number 7,705,723 outlines a method and apparatus to provide outbreak notifications based on historical location data. Leveraged together, a device containing multiple sensors to collect patient-state information, geospatial data, and other sensor data may be used to calculate information about the active state of the user that is more accurate than would be possible using standalone sensors. This data may in turn be used to issue accurate and effective outbreak notifications.
For example, if an individual is identified as a point source of disease, the patented system can backtrack all potential contact points for the affected individual and notify anyone who was potentially in close contact. Furthermore, the data collected can be used to identify areas that may be affected, paths of intersection, quarantine, distributions of medicine such as Tamiflu®, along with a map of the outbreak. A system such as this enables the real-time understanding, management, and containment of outbreaks of disease, including potential pandemics.
The Fullpower Patent Portfolio
These patents are part of an intellectual property portfolio from Fullpower-MotionX that includes more than 36 issued patents with dozens of patents pending. Broad coverage for the MotionX Technology Platform introduces a new and necessary approach for sleep, heart disease, Alzheimer's, diabetes, and epidemics. These advanced methodologies can enhance the potential of pharmaceutical drugs such as Ambien® (SNY) or Zocor® (MRK), for example. Fullpower's continued innovation translates into constantly broadening and deepening of the IP related to the MotionX patent portfolio for non-invasive wearable wireless devices.
About Fullpower and the MotionX Technology Platform
Founded in 2003 by a world-class team, Fullpower's MotionX technology platform leads the wearable technology revolution. The MotionX Technology Platform is a suite of tightly coupled and integrated firmware, software and communication components that are the building blocks for new breakthrough non-invasive, wearable wireless devices. With a broad IP portfolio including several dozen patents, the MotionX Technology Platform powers leading solutions from companies such as Nike, Jawbone, Apple, Comcast, Pioneer, JVC, and others. Fullpower showcases its MotionX Technology Platform via its iPhone and iPad applications, which lead the iTunes store in the Medical, Health & Fitness and Navigation categories.
Image Available: www2.marketwire.com/mw/frame_mw?attachid=2195463
Add to Digg : digg.com/submit?phase=2&url= www2.marketwire.com/mw/release_html_b1?release_id=971734
Bookmark with del.icio.us : del.icio.us/post?v=4&noui&jump=close&url= www2.marketwire.com/mw/release_html_b1?release_id=971734
Add to Newsvine : www.newsvine.com/_tools/seed&save?u= www2.marketwire.com/mw/release_html_b1?release_id=971734
Email Contact : www2.marketwire.com/mw/emailprcntct?id=EF0F89A749E5CA59